Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.
about
Animal models for Ebola and Marburg virus infectionsMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesEbola virus antibody prevalence in dogs and human riskTransmission of Ebola virus from pigs to non-human primatesEbola virus disease and critical illness.Aerosol Transmission of FilovirusesOcular Manifestations of Ebola Virus Disease: An Ophthalmologist's Guide to Prevent Infection and PanicVaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsTransmission of Ebola viruses: what we know and what we do not knowUnderstanding ebola virus transmissionNeglected filovirusesCirculating microRNA profiles of Ebola virus infectionPartitioning of Viruses in Wastewater Systems and Potential for AerosolizationPersonal Protective Equipment: Protecting Health Care Providers in an Ebola OutbreakThe face of Ebola: changing frequency of haemorrhage in the West African compared with Eastern-Central African outbreaksPreparing for imported Ebola cases in Israel, 2014 to 2015.What is Ebola?Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain)Ebola hemorrhagic fever transmission and risk factors of contacts, UgandaA nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.Ebola virus-like particles protect from lethal Ebola virus infection.Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe diseaseFilovirus vaccines.Towards a vaccine against Ebola virus.Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesProgress in filovirus vaccine development: evaluating the potential for clinical use.Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.Development of a model for marburgvirus based on severe-combined immunodeficiency mice.Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animalsChimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge.Replication-deficient ebolavirus as a vaccine candidate.Clinical presentation and management of severe Ebola virus disease.Ebola virus disease: societal challenges and new treatments.Ebola Virus Shedding and Transmission: Review of Current Evidence.Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing?Multiscale model for pedestrian and infection dynamics during air travel.Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study.
P2860
Q21131118-375A714A-6D9A-45BF-800F-A28E44DDD424Q21562420-C4EADE8B-247C-4A0C-8E87-8D64DAC1693EQ22305651-EF83DE2B-1E8D-4B0A-B029-87B5C1D23FAEQ24612028-11467F0B-CC88-4AEE-9782-DD480E6EFFCCQ26250274-D7789A14-BCE4-4941-8E86-BF27B771E371Q26745989-98276B83-8322-415F-B096-DC39CB0B4CDBQ26777816-4C1072F4-8999-48DF-ADB6-12E5F8FA404FQ27485491-17811ACF-B441-47C1-A40B-C324FF82CF8AQ28083565-0D1B36E9-8F5D-4E48-910A-6C4901A8CAF4Q28088529-F32FF55B-AFF0-45F1-A03E-3A79BC3FC3EAQ28383265-7BD25EF1-FB93-4FB5-A7D7-E3D11B2FBC5FQ28392668-94DA3C43-60F6-4B43-ACCC-A60E533CB7B5Q28394395-42AC8591-10BC-44D6-9041-6988FE59655BQ28394811-337AF0D4-7528-4C33-901A-5E31481649E6Q28606458-D187C133-DF96-4E08-BBD8-E19D34FA86CCQ30202114-14ED92EB-1346-484A-A813-8B69AB3A6D06Q30205723-ECB8AC5E-92A6-45BB-9264-6BACB2A8DAE4Q33941423-31632776-6071-4C72-883D-9268D1EEBD43Q33975086-38BBE80B-D5B2-4675-9F19-3F2A16F15AB7Q34029668-B630B23A-74BB-4A59-B557-4BF413D15420Q34792924-4A717204-85ED-40FF-A07A-DB4D78FB9298Q35047909-8803044F-8137-4242-9F21-D13B167D2A67Q35535734-1D3356DD-B310-47F7-BBC8-299D24919EA3Q35558539-49D8BF3C-AA36-4501-B3BE-738593C6212AQ35623381-D8596D6B-C685-4F07-8CB3-BA56B25B72AEQ36040533-588F4B3D-4094-4F79-AE97-51A812B961FEQ36100545-29D086C4-1D74-429A-8306-D7049B785CEEQ36138983-55834FC8-465D-4D6C-BF8D-98EC74291677Q36310674-CFDAAB81-0DC1-4C30-9FF4-3F3573DFC1C7Q36370336-FB98CC4F-8723-4F80-94B7-47D7A56FC1D5Q36844471-33C7BE74-1366-49A3-B44D-1A70E48DF95EQ37113787-2BC3EAB7-8196-416B-B47B-BA7C4BC3958AQ37145203-E0626494-762F-4E4A-A494-653232A4D82DQ38264960-A0E3B561-8034-4933-92A8-996DD8548104Q38388679-A1E0C825-629D-4452-B3A8-BD306A884DD0Q38904658-9682DAD8-5DCA-4AF8-9D07-51BB8AA11CD4Q38914896-BF956098-9A64-477F-9F39-7C46177DD7BAQ40052360-E77CFA4E-CC99-4D3C-9DF5-B683941772B0Q40067156-59452821-5FD1-49E2-8FA6-0EA20AADF9D0Q40161391-80F172D5-F891-464F-9DD6-C9ADE357D9A1
P2860
Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@ast
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@en
Transmission of Ebola virus
@nl
type
label
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@ast
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@en
Transmission of Ebola virus
@nl
prefLabel
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@ast
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@en
Transmission of Ebola virus
@nl
P2093
P1433
P1476
Transmission of Ebola virus (Z ...... n a biocontainment laboratory.
@en
P2093
J Geisbert
P Jahrling
T Geisbert
P304
P356
10.1016/S0140-6736(95)92841-3
P407
P433
P577
1995-12-01T00:00:00Z